Rass, Verena http://orcid.org/0000-0002-4241-5891
Ianosi, Bogdan-Andrei
Zamarian, Laura
Beer, Ronny
Sahanic, Sabina
Lindner, Anna
Kofler, Mario
Schiefecker, Alois Josef
Mahlknecht, Philipp
Heim, Beatrice
Limmert, Victoria
Sonnweber, Thomas
Pizzini, Alex
Tymoszuk, Piotr
Scherfler, Christoph
Djamshidian, Atbin
Kiechl, Stefan
Tancevski, Ivan
Seppi, Klaus
Pfausler, Bettina
Loeffler-Ragg, Judith
Helbok, Raimund
Funding for this research was provided by:
University of Innsbruck and Medical University of Innsbruck
Article History
Accepted: 10 September 2021
First Online: 28 September 2021
Declarations
:
: KS reports grants from FWF Austrian Science Fund, grants from Michael J. Fox Foundation, grants from International Parkinson and Movement Disorder Society, personal fees from Teva, personal fees from UCB, personal fees from Lundbeck, personal fees from AOP Orphan Pharmaceuticals AG, personal fees from Abbvie, personal fees from Roche, and personal fees from GrĂ¼nenthal; all outside the submitted work. PM reports grants from TWF (Tyrolean Science Fund), grants from Medtronic, personal fees from Boston Scientific, all outside the submitted work. The other authors have nothing to disclose. All other authors declare no competing interests.
: The local ethics committee approved the conduct of the study (Medical University of Innsbruck, EK Nr: 1103/2020), which was registered at ClinicalTrials.gov (NCT04416100).
: All patients gave written informed consent according to local regulations and study procedures conformed to the Declaration of Helsinki.